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• 237 one-off clinical medication reviews were completed in 8 care homes on patients registered in 7 GP practices. 
• Each review took on average 1 hour 20 minutes at a cost of £38.50 per patient (based on pharmacist’s time), involved a variety of interventions 
and resulted in an average annual cost savings of £94 per patient (based only on medication costs). 
• The data provides evidence for the impact both upon the improved quality of prescribing and cost reduction which a suitably trained 
pharmacist can have in providing clinical medication reviews for patients in care homes.
• There is no consensus on the most effective method of undertaking clinical 
medication reviews in care homes1. 
• The Care Home Use of Medicines Study Report2 recommends that pharmacists 
should clinically review all care home residents and their medications for 
appropriateness on at least 6 monthly intervals. 
• A primary care pharmacist was employed by the local GP commissioning 
group to undertake clinical medication reviews in care homes. The aim was to 
achieve quality medication reviews, not necessarily cost savings. 
Medication reviews were carried out by the pharmacist according to an 
agreed protocol and included assessing the need for continuing therapy, 
ensuring appropriate monitoring, screening for drug interactions and 
adverse effects. Recommendations and changes were discussed and agreed 
with GPs, then actioned, recorded and communicated by the pharmacist. A 
record of interventions including the relevant cost savings at the time was 
recorded for the purpose of evaluating the project at year-end. Several 
criteria were recorded to determine the quality of the reviews, including the 
type of recommendation made; number of recommendations agreed for 
action by the GP; reduction in number of repeat prescription items; and cost 
savings. In some practices, the number of unmet Quality and Outcome 
Framework (QOF) targets which were met during the medication review was 
also recorded. Ethics committee approval was not required.
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• 237 medication reviews were completed in 8 care homes, both nursing and residential, taking 326.5 hours at a cost of approximately £9,320 (based on rate of 
£28/hour). 
• The average reduction in number of repeat items ranged from 0 to 15 items, depending on the home and the GP practice. 
• Of the 780 recommendations made, 717 (92%) were agreed by the GPs, suggesting a high level of satisfaction with the service. Table 1 lists the breakdown of 
intervention type. (Figure 1)
• The estimated annual savings in terms of medication costs (medication stopped, amended, switched) totalled £22,300, resulting in an annual net saving of almost 
£13,000. (Figure 2)
The evaluation demonstrates that the service of a suitably qualified and experienced pharmacist may be a cost effective way of undertaking clinical medication 
reviews in care homes. These findings add to the relatively small published evidence base for the effectiveness of primary care pharmacists in undertaking this type 






















Figure 1. % Breakdown of Agreed Recommendations n=717 Figure 2. Estimated Annual Cost Savings £s Per Practice
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